Factor VIII inhibitors in hemophilia A treated with emicizumab
Por um escritor misterioso
Descrição
PDF) Emicizumab (Hemlibra®) in hemophilia A patients with
Emicizumab Prophylaxis in Hemophilia A with Inhibitors
Paradigm shifts in haemophilia A therapy with emicizumab
Diagnostics, Free Full-Text
Use of chromogenic Factor VIII activity determination in
Hemophilia Treatment Market Share Outlook 2022-2028
Determining the Approximate Factor VIII Level Equivalency of
National Hemophilia Foundation (NHF) - Posters - Characteristics
How HEMLIBRA® (emicizumab-kxwh) Works
de
por adulto (o preço varia de acordo com o tamanho do grupo)
